Verve Therapeutics, Inc. (VERV)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch VERV
See up to 3 months of VERV. The 7-day demo opens the 1M and 3M ranges and puts VERV on your watchlist.
Start 7-day demoLatest VERV insider trades
About Verve Therapeutics, Inc. (VERV)
Verve Therapeutics, Inc. files with the SEC under CIK 0001840574 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
VERV Form 4 activity by transaction type, last 90 days
No Form 4 activity for VERV in the last 90 days.
VERV insider transactions (Form 4)
8118 Form 4 filings on record, the earliest from Dec 3, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Joan Nickerson - Officer | Other | Common Stock | 17,420 | - | - | |
| Joan Nickerson - Officer | Derivative | Stock Option (right to buy) | 225,000 | - | - | |
| Joan Nickerson - Officer | Derivative | Restricted Stock Units | 40,000 | - | - | |
| Joan Nickerson - Officer | Derivative | Restricted Stock Units | 18,000 | - | - | |
| Joan Nickerson - Officer | Derivative | Restricted Stock Units | 6,630 | - | - | |
| Joan Nickerson - Officer | Derivative | Stock Option (right to buy) | 102,016 | - | - | |
| Joan Nickerson - Officer | Derivative | Stock Option (right to buy) | 125,000 | - | - | |
| Sekar Kathiresan - Officer | Other | Common Stock | 348,431 | - | - | |
| Sekar Kathiresan - Officer | Other | Common Stock | 110,997 | - | - | |
| Sekar Kathiresan - Officer | Other | Common Stock | 240,997 | - | - | |
| Sekar Kathiresan - Officer | Derivative | Stock Option (right to buy) | 488,000 | - | - | |
| Sekar Kathiresan - Officer | Derivative | Stock Option (right to buy) | 150,000 | - | - | |
| Sekar Kathiresan - Officer | Derivative | Restricted Stock Units | 120,000 | - | - | |
| Sekar Kathiresan - Officer | Derivative | Restricted Stock Units | 99,000 | - | - | |
| Sekar Kathiresan - Officer | Derivative | Stock Option (right to buy) | 138,995 | - | - | |
| Sekar Kathiresan - Officer | Derivative | Stock Option (right to buy) | 167,425 | - | - | |
| Sekar Kathiresan - Officer | Derivative | Stock Option (right to buy) | 500,203 | - | - | |
| Sekar Kathiresan - Officer | Derivative | Stock Option (right to buy) | 75,105 | - | - | |
| Sekar Kathiresan - Officer | Derivative | Stock Option (right to buy) | 431,988 | - | - | |
| Sekar Kathiresan - Officer | Derivative | Stock Option (right to buy) | 526,000 | - | - | |
| Troy Lister - Officer | Other | Common Stock | 6,952 | - | - | |
| Troy Lister - Officer | Derivative | Stock Option (right to buy) | 225,000 | - | - | |
| Troy Lister - Officer | Derivative | Restricted Stock Units | 40,000 | - | - | |
| Troy Lister - Officer | Derivative | Restricted Stock Units | 12,075 | - | - | |
| Troy Lister - Officer | Derivative | Restricted Stock Units | 6,630 | - | - | |
| Troy Lister - Officer | Derivative | Stock Option (right to buy) | 32,000 | - | - | |
| Troy Lister - Officer | Derivative | Stock Option (right to buy) | 69,500 | - | - | |
| Jason Politi - Officer | Other | Common Stock | 16,405 | - | - | |
| Jason Politi - Officer | Derivative | Stock Option (right to buy) | 225,000 | - | - | |
| Jason Politi - Officer | Derivative | Restricted Stock Units | 40,000 | - | - | |
| Jason Politi - Officer | Derivative | Restricted Stock Units | 6,630 | - | - | |
| Jason Politi - Officer | Derivative | Restricted Stock Units | 16,500 | - | - | |
| Jason Politi - Officer | Derivative | Stock Option (right to buy) | 118,796 | - | - | |
| Jason Politi - Officer | Derivative | Stock Option (right to buy) | 25,000 | - | - | |
| Jason Politi - Officer | Derivative | Stock Option (right to buy) | 90,000 | - | - | |
| Sheila Mikhail | Derivative | Stock Option (right to buy) | 136,139 | - | - | |
| Sheila Mikhail | Derivative | Stock Option (right to buy) | 42,200 | - | - | |
| Sheila Mikhail | Derivative | Stock Option (right to buy) | 43,198 | - | - | |
| Ourania Tatsis | Derivative | Stock Option (right to buy) | 267,541 | - | - | |
| Ourania Tatsis | Derivative | Stock Option (right to buy) | 42,200 | - | - | |
| Alexander Cumbo | Derivative | Stock Option (right to buy) | 136,139 | - | - | |
| Alexander Cumbo | Derivative | Stock Option (right to buy) | 42,200 | - | - | |
| GV 2017 GP, L.L.C. | Other | Common Stock | 6,108,442 | - | - | |
| GV 2017 GP, L.L.C. | Other | Common Stock | 4,260,047 | - | - | |
| GV 2017 GP, L.L.C. | Other | Common Stock | 1,800,000 | - | - | |
| Allison Dorval - Officer | Other | Common Stock | 13,280 | - | - | |
| Allison Dorval - Officer | Derivative | Stock Option (right to buy) | 258,000 | - | - | |
| Allison Dorval - Officer | Derivative | Stock Option (right to buy) | 75,000 | - | - | |
| Allison Dorval - Officer | Derivative | Restricted Stock Units | 45,000 | - | - | |
| Allison Dorval - Officer | Derivative | Restricted Stock Units | 33,750 | - | - | |
| Allison Dorval - Officer | Derivative | Restricted Stock Units | 1,875 | - | - | |
| Allison Dorval - Officer | Derivative | Stock Option (right to buy) | 180,000 | - | - | |
| Jodie Pope Morrison | Derivative | Stock Option (right to buy) | 267,541 | - | - | |
| Jodie Pope Morrison | Derivative | Stock Option (right to buy) | 42,200 | - | - | |
| Lonnel Coats | Derivative | Stock Option (right to buy) | 136,139 | - | - | |
| Lonnel Coats | Derivative | Stock Option (right to buy) | 42,200 | - | - | |
| Krishna Yeshwant | Other | Common Stock | 6,108,442 | - | - | |
| Krishna Yeshwant | Other | Common Stock | 4,260,047 | - | - | |
| Krishna Yeshwant | Other | Common Stock | 1,800,000 | - | - | |
| Krishna Yeshwant | Derivative | Stock Option (right to buy) | 136,139 | - | - | |
| Krishna Yeshwant | Derivative | Stock Option (right to buy) | 42,200 | - | - | |
| Andrew D. Ashe - Officer | Other | Common Stock | 348,828 | - | - | |
| Andrew D. Ashe - Officer | Derivative | Stock Option (right to buy) | 225,000 | - | - | |
| Andrew D. Ashe - Officer | Derivative | Restricted Stock Units | 40,000 | - | - | |
| Andrew D. Ashe - Officer | Derivative | Restricted Stock Units | 27,000 | - | - | |
| Andrew D. Ashe - Officer | Derivative | Stock Option (right to buy) | 107,997 | - | - | |
| Andrew D. Ashe - Officer | Derivative | Stock Option (right to buy) | 153,278 | - | - | |
| Andrew D. Ashe - Officer | Derivative | Stock Option (right to buy) | 26,999 | - | - | |
| Andrew D. Ashe - Officer | Derivative | Stock Option (right to buy) | 150,000 | - | - | |
 Michael F. Maclean | Derivative | Stock Option (right to buy) | 136,139 | - | - | |
| Michael F. Maclean | Derivative | Stock Option (right to buy) | 42,200 | - | - | |
 Burt A. Adelman | Other | Common Stock | 428,326 | - | - | |
| Burt A. Adelman | Derivative | Stock Option (right to buy) | 136,139 | - | - | |
| Burt A. Adelman | Derivative | Stock Option (right to buy) | 42,200 | - | - | |
| Burt A. Adelman | Derivative | Stock Option (right to buy) | 43,198 | - | - | |
| Burt A. Adelman | Grant or award | Stock Option (right to buy) | 42,200 | $0.00 | - | |
| Sekar Kathiresan - Officer | Gift | Common Stock | 30,000 | $0.00 | - | |
| Sekar Kathiresan - Officer | Gift | Common Stock | 30,000 | $0.00 | - | |
| Allison Dorval - Officer | Option exercise | Common Stock | 1,875 | - | - | |
| Allison Dorval - Officer | Open-market sale | Common Stock | 555 | $5.64 | $3K | |
| Allison Dorval - Officer | Option exercise | Restricted Stock Units | 1,875 | $0.00 | - |
VERV insider trading FAQ
What is the latest insider trade for VERV?
Verve Therapeutics, Inc. (VERV) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-07-25. The full record for VERV runs to 18 Form 4 filings, the earliest from 2024-12-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VERV stock?
No insider purchases of VERV were filed in the last 90 days.
How many insiders are selling VERV stock?
No insider sales of VERV were filed in the last 90 days. 1 sale is on record for this company.
Where can I see VERV SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VERV Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Joan Nickerson view on EDGAR
- - Sekar Kathiresan view on EDGAR
- - Troy Lister view on EDGAR
- - Jason Politi view on EDGAR
- - Sheila Mikhail view on EDGAR
- - Ourania Tatsis view on EDGAR
- - Alexander Cumbo view on EDGAR
- - GV 2017 GP, L.L.C. view on EDGAR
- - Allison Dorval view on EDGAR
- - Jodie Pope Morrison view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where VERV's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VERV with a 7-day demo
- VERV on your watchlist
- Every VERV Form 4 filing on record
- Up to 3 months of VERV price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
